Stock listing

CRNX Stock Price, News, Filings & Events — Crinetics Pharmaceuticals, Inc.

Selected listing: CRNX · NASDAQ · USD · US

CRNX:NASDAQ is the primary listing for Crinetics Pharmaceuticals, Inc., a company dedicated to creating innovative therapies for endocrine diseases and disorders. With a market capitalization of around $8.87 billion, Crinetics is actively engaged in advancing its pipeline of treatments. Recent news and filings may provide insights into the company's progress and strategic direction within the biopharmaceutical industry. Investors can stay informed about upcoming events that could impact the company's performance and market presence.

CRNX:NASDAQUSDUSUpdated July 24, 2026
Crinetics Pharmaceuticals, Inc. logo
Ticker
CRNX:NASDAQ
Asset type
Stock
Market cap
$8.87B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Crinetics Pharmaceuticals, Inc. CRNX:NASDAQ stock context

CRNX:NASDAQ is the primary listing for Crinetics Pharmaceuticals, Inc., a company dedicated to creating innovative therapies for endocrine diseases and disorders. With a market capitalization of around $8.87 billion, Crinetics is actively engaged in advancing its pipeline of treatments. Recent news and filings may provide insights into the company's progress and strategic direction within the biopharmaceutical industry. Investors can stay informed about upcoming events that could impact the company's performance and market presence.

Research Crinetics Pharmaceuticals, Inc.

Alternate listings